Life
Briefing: High-throughput platform helps engineer fast-acting covalent protein drugs
Strategic angle: A team at Westlake University has developed a new platform to create rapid-acting protein therapeutics.
editorial-staff
1 min read
Updated 8 days ago
A research team at Westlake University, led by Bobo Dang and Ting Zhou, has created a high-throughput platform specifically designed for the engineering of covalent protein therapeutics.
This platform focuses on improving the efficiency of developing rapid-acting protein drugs, which could significantly impact therapeutic timelines and patient outcomes.
The implications of this technology extend to various applications in biotechnology, potentially streamlining processes in drug development and increasing throughput in therapeutic production.